Sat, Nov 29, 2014, 2:31 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Therapy Cells, Inc. Message Board

  • danielmartin379 danielmartin379 Mar 26, 2014 12:56 PM Flag


    I know of two other companies in the same field( hart & nbs) but tcel has patent #11/702,895. The other two has not indicated any patent numbers on yahoo. Will other companies pay royalties to tcel?

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Most probably ... and another scenario could be a "buy-out" by one of the many "big-bio-brothers" ... imagine for a moment a buy out opporunity at 2 bucks?? ... in the meantime TCEL is the only Bio not loosing ground in these "dies horribilis" ...

      Sentiment: Strong Buy

      • 2 Replies to arpwaveitalia
      • I looked at the Patent details thoroughly and convinced the upside potential is huge.

        If treatment to Horses are considered and it can be directly applied to Humans then their approval for Human treatment is assured. I'm looking atleast $1 per share in the near future.

        A response from the company will add value at this juncture, however if they keep quiet, that is the way they operate.

        For shorties and newbies google this Patent # and read through. It is not a hoax.


        Sentiment: Strong Buy

      • Not losing ground. Its so small that it trades on a whim. It went up to 0.002 and now back at 0.001. Guess what -I bought 400 k today at that price. I just have a feeling that the patent is worth buying into. Dont know anything about the company or who is in charge despite repeated attempts to get hold of anyone. However I took a small speculation risk based purely on the patent alone and its worth to another company.

0.0005-0.0001(-16.67%)Nov 28 11:34 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Chevron Corporation
NYSEFri, Nov 28, 2014 1:00 PM EST